Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
1. Abbott Labs' shares fell 5.1% in pre-market trading. 2. Third-quarter adjusted EPS guidance below analysts' expectations. 3. Company's sales beat market estimates at $11.142 billion. 4. Adjusted earnings reported at $1.26, slightly above estimates. 5. Future adjusted EPS guidance ranges from $1.28 to $1.32.